Scintilla to acquire Scilex Pharmaceuticals
Tuesday, August 09, 2016
Scintilla Pharmaceuticals Inc in consideration for deal, Scilex equity holders to receive up to $70 million in stock of Scintilla, after next equity financing of Scintilla.
Has entered into a binding term sheet to acquire Scilex Pharmaceuticals, Inc.
Acquisition is contingent upon completion of each parties' due diligence and other customary closing conditions.
Source : reuters.com
